Evaluation of Blood Cytotoxicity Against Tumor Cells Using a Live-Cell Imaging Platform

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• Cellular cytotoxicity, mediated by cytotoxic T lymphocytes and natural killer (NK) cells, is vital for immune defense against infections and tumors.
• In lung cancer, a significant portion of patients exhibit impaired intratumoral NK cell function and lack Human Leukocyte Antigen Class I (HLA-I) expression, a key factor for NK cell activation.
• Absent self-recognition, where tumor cells evade NK cell detection due to lack of HLA-I, presents a challenge in cancer immunotherapy.

Purpose of the Study:

• To explore the potential of NK cell cytotoxicity as a predictive biomarker in oncology, specifically for informing patient status and treatment response.
• To develop and validate a novel, rapid assay for quantifying NK cell cytotoxicity using minimal biological samples.

Main Methods:

• Utilized the IncuCyte live imaging system for real-time monitoring of cellular interactions.
• Developed a streamlined protocol for assessing NK cell cytotoxicity requiring small blood volumes and reduced reagent usage.
• Focused on analyzing NK cell activity in the context of lung cancer and HLA-I expression.

Main Results:

• Demonstrated a simple and rapid method for measuring NK cell cytotoxicity.
• The developed assay requires minimal blood samples and processing time, making it clinically practical.
• Investigated the role of NK cell cytotoxicity as a potential biomarker in lung cancer.

Conclusions:

• NK cell cytotoxicity can be effectively measured using a novel, rapid, and low-volume assay.
• This assay holds promise as a valuable biomarker for assessing patient status and predicting treatment outcomes in lung cancer.
• The findings support the clinical utility of NK cell activity assessment in personalized oncology.